Nihon Kohden (OTCMKTS:NHNKY) Shares Gap Up – Time to Buy?

Nihon Kohden Corporation (OTCMKTS:NHNKY) shares gapped up before the market opened on Tuesday . The stock had previously closed at $9.05, but opened at $9.4499. Nihon Kohden shares last traded at $9.4499, with a volume of 219 shares traded.

Wall Street Analyst Weigh In

Separately, Zacks Research raised shares of Nihon Kohden to a “hold” rating in a research report on Monday, April 27th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy”.

Nihon Kohden Stock Performance

The stock has a market capitalization of $1.57 billion, a price-to-earnings ratio of 15.89 and a beta of 0.39. The company has a fifty day simple moving average of $8.95 and a two-hundred day simple moving average of $10.00.

Nihon Kohden (OTCMKTS:NHNKY) last released its earnings results on Thursday, May 14th. The company reported $0.34 earnings per share for the quarter, beating analysts’ consensus estimates of $0.24 by $0.10. The firm had revenue of $453.10 million during the quarter, compared to the consensus estimate of $414.40 million. Nihon Kohden had a return on equity of 9.46% and a net margin of 6.08%. As a group, equities analysts anticipate that Nihon Kohden Corporation will post 0.6 earnings per share for the current year.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.